Envista Holdings Corporation (NVST)
After hours:
| Previous close | 42.76 |
| Open | 42.97 |
| Bid | 41.48 x 900 |
| Ask | 41.48 x 1100 |
| Day's range | 41.04 - 43.14 |
| 52-week range | 34.50 - 46.88 |
| Volume | |
| Avg. volume | 1,319,377 |
| Market cap | 6.681B |
| Beta (5Y monthly) | 1.75 |
| PE ratio (TTM) | 20.28 |
| EPS (TTM) | 2.04 |
| Earnings date | 09 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 51.33 |
- PR Newswire
Envista Schedules Fourth Quarter 2021 Earnings Call
Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2021 on Wednesday, February 9, 2022. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.
- PR Newswire
Envista and Pacific Dental Services Announce Assisted Intelligence Development Partnership
Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista and leading dental support organization Pacific Dental Services® (PDS) announce today the consummation of a multi-year year development partnership, created to harness the power of Assisted Intelligence (AI) in support of clinical image analysis across the dental market.
- PR Newswire
Envista Closes Divestiture of KaVo Treatment Unit & Instrument Business
Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that it closed the previously disclosed divestiture of its KaVo Treatment Unit & Instrument business. Envista received $317.3 million in cash on the closing date and expects to receive total gross proceeds of $383 million, which includes an earnout and certain adjustments to be paid out by the first half of 2022. Envista will use the proceeds to fund strategic acquisitions and internal investments.
